Gregory Louis Merril - 14 Apr 2025 Form 4/A - Amendment Insider Report for BiomX Inc. (PHGE)

Role: Director
Signature: /s/ Greg Merril
Issuer symbol: PHGE
Transactions as of: 14 Apr 2025
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 21 Apr 2025, 08:24:29 UTC
Date Of Original Report: 18 Apr 2025
Previous filing: 15 Jul 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHGE	Common Stock Options - right to Buy	Award	$0	+17,600		$0.000000	17,600	14 Apr 2025	Common Stock	17,600	$0.5380	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years.

Remarks:

This amendment is being filed solely to correct an administrative error in Table II, Column 5. The number of derivative securities acquired was inadvertently reported under (D) of Column 5 instead of (A). No other changes have been made to the originally filed Form 4.